Market revenue in 2023 | USD 22.8 million |
Market revenue in 2030 | USD 31.7 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Biomaterials |
Fastest growing segment | Skin-substitutes |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biomaterials, Skin-substitutes, Growth Factors |
Key market players worldwide | Smith & Nephew PLC, MiMedx Group Inc, Organogenesis Holdings Inc Class A, Bic, Integra Lifesciences Holdings Corp, Osiris Corp, Stryker Corp, Tissue Regenix, Cytori Therapeutics, Solsys Medical, Osiris Therapeutics, Human BioSciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active wound care market will help companies and investors design strategic landscapes.
Biomaterials was the largest segment with a revenue share of 44.3% in 2024. Horizon Databook has segmented the Australia active wound care market based on biomaterials, skin-substitutes, growth factors covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia active wound care market , including forecasts for subscribers. This country databook contains high-level insights into Australia active wound care market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account